Clinical Trial Update: To Evaluate the Efficacy and Safety of JS002 in HoFH Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of JS002 in patients with homozygous familial hypercholesterolemia (HoFH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• JS002

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Hyperlipemia | Phase 2 | Status: COMPLETED